MAPT and Alzheimer disease: Their experiments showed that hiPSC-NSC-EVs induced changes in the transcriptome of microglia and reactive astrocytes, which suppressed neuroinflammatory signaling in an AD model and reduced the accumulation of amyloid-β plaques and P-Tau.